Vitamin D is one of the few supplements with randomised-trial evidence pointing to slower biological ageing, not just better bone health. In 2025, a sub-study of the large VITAL trial reported that vitamin D3 supplementation sharply reduced the shortening of telomeres over four years. That is a genuine signal worth understanding — but the picture around vitamin D and biological age is more nuanced than a headline, and most of the benefit appears concentrated in people who were deficient to begin with.
What the VITAL telomere sub-study actually found
VITAL (the VITamin D and OmegA-3 TriaL) was a randomised, double-blind, placebo-controlled study of vitamin D3 at 2,000 IU/day and marine omega-3 at 1 g/day, enrolling older US adults — women aged 55 and over, men aged 50 and over — and following them for roughly five years. It was designed primarily to test cancer and cardiovascular outcomes.
A pre-specified telomere sub-study, co-led by researchers at Mass General Brigham and the Medical College of Georgia and published in The American Journal of Clinical Nutrition in 2025, measured leukocyte telomere length (the length of the protective caps on chromosomes in white blood cells) in just over 1,000 participants at baseline, year 2 and year 4.
The result was striking. Telomeres in the placebo group shortened at the pace you would expect with ageing, while vitamin D3 supplementation almost entirely blunted that loss over the four years. The investigators described the effect as preventing the equivalent of nearly three years of ageing at the cellular level compared with placebo. Omega-3 supplementation, by contrast, had no significant effect on telomere length in the same study.
Telomere attrition is one of the recognised hallmarks of ageing: as cells divide and accumulate oxidative and inflammatory stress, telomeres shorten until cells senesce. Slowing that process is biologically meaningful, and VITAL is the first large, long-term randomised trial to show that a supplement can protect telomere length in humans rather than merely correlate with it.
How to read the “three years of ageing” claim
This is where the house rule of hype-versus-reality matters. Telomere length is a legitimate biomarker, but it is noisy, and it is not the same as a validated epigenetic clock or a clinical endpoint. The three-year figure is a within-study comparison of base-pair loss, not a promise that taking vitamin D makes you three years younger in any practical sense.
It is also worth noting what VITAL did and did not show overall. The parent trial did not demonstrate large reductions in total cancer incidence or major cardiovascular events in the general, largely vitamin-D-replete population, though it did suggest benefits for advanced and fatal cancer, autoimmune disease and markers of inflammation. The telomere finding adds a mechanistic layer: vitamin D appears to act on pathways — inflammation and oxidative stress among them — that plausibly link to slower cellular ageing.
Plausible mechanisms
Vitamin D is not really a vitamin in the classic sense; its active form is a steroid hormone with receptors in most tissues of the body. Several mechanisms could connect it to biological ageing:
- Inflammation. Vitamin D modulates immune signalling and has been associated with lower levels of inflammatory markers. Chronic low-grade inflammation (“inflammaging”) accelerates telomere loss and cellular senescence.
- Oxidative stress. By supporting antioxidant defences, adequate vitamin D may reduce the oxidative damage that erodes telomeres.
- Telomerase and cell turnover. Some laboratory work suggests vitamin D influences telomerase activity, the enzyme that maintains telomere length, though human evidence here is still indirect.
These mechanisms are coherent rather than proven in detail. The honest summary is that vitamin D plausibly protects against several ageing pathways at once, and VITAL gives the first hard randomised evidence for one of them.
Why deficiency is so common in Asia and among indoor professionals
Here is the paradox that matters most for readers in Singapore and across tropical Asia: year-round sunshine does not guarantee adequate vitamin D. Deficiency is widespread, and it is largely a lifestyle problem.
Singapore’s own data illustrate this. A workplace study of indoor workers found roughly a third were vitamin D deficient, and the country’s National Health Survey has previously estimated that around 40% of Singaporeans fall short, with a smaller group severely deficient. Office workers carried a markedly higher risk than those who spent time outdoors. The drivers are familiar to any executive: air-conditioned buildings, long indoor hours, sun avoidance, diligent sunscreen use and clothing that limits skin exposure. Skin pigmentation also reduces vitamin D synthesis for a given amount of sun, which matters across the region’s populations.
In other words, the people most likely to be reading about longevity — desk-bound professionals who commute between home, car and office — are among those most likely to be running low. If you are tracking your biological age in Singapore, vitamin D status is one of the cheapest and most correctable inputs you can address.
Sensible testing and dosing
The practical takeaway is not “everyone should megadose.” It is “find out where you stand, then correct a deficiency.” Vitamin D is one of the few markers that belongs on a basic longevity panel precisely because deficiency is common, consequential and easy to fix.
Testing. A 25-hydroxyvitamin D [25(OH)D] blood test is the standard measure. It is inexpensive and widely available in Singapore, and it is a sensible part of a broader workup — see our guide to which longevity tests actually matter. Retesting after a few months of supplementation confirms you have reached a healthy range without overshooting.
Dosing. The VITAL dose was 2,000 IU/day of D3, a level most guidelines consider safe for long-term use in adults. Many clinicians dose to target — adjusting based on your measured 25(OH)D level — rather than applying a blanket number. More is not automatically better: very high intakes can cause hypercalcaemia and offer no added longevity benefit, and the telomere protection in VITAL came from a modest, physiological dose, not a heroic one. Taking D3 with a meal containing fat improves absorption, and some practitioners pair it with vitamin K2 and adequate magnesium, though the evidence for those combinations is weaker than for correcting deficiency itself.
If you are pregnant, have kidney disease, sarcoidosis or a history of high calcium, dosing should be individualised with a clinician rather than self-directed.
Frequently asked questions
Does vitamin D actually reverse biological age?
No. The VITAL telomere sub-study showed that vitamin D3 slowed telomere shortening over four years compared with placebo — it preserved telomere length rather than lengthening it. That is slowing one marker of ageing, not reversing age. It is still one of the strongest randomised signals we have for any supplement.
How much vitamin D should I take for longevity?
The trial evidence comes from 2,000 IU/day of D3, which is widely regarded as safe for adults. The better approach is to test your 25(OH)D level, correct any deficiency and retest, rather than guessing. Very high doses add risk without added benefit.
If I live in a sunny country, do I still need to worry?
Yes. Deficiency is common across tropical Asia, including Singapore, because indoor lifestyles, air conditioning, sun avoidance and sunscreen limit the skin’s production. Studies of Singaporean indoor workers have found roughly a third deficient. Sunshine outdoors does not help if you rarely step into it.
Did omega-3 help telomeres in the same trial?
No. In VITAL, marine omega-3 at 1 g/day showed no significant effect on telomere length. Omega-3 has other evidence for biological ageing from separate trials, but telomere protection in VITAL was specific to vitamin D.
The takeaway
Vitamin D will not make anyone biologically younger, and the longevity field has learned to be sceptical of single-supplement salvation stories. But the 2025 VITAL telomere finding is one of the rare cases where a cheap, widely available intervention has randomised evidence behind a credible anti-ageing mechanism. For professionals in Singapore and across Asia — where deficiency is common despite the climate — the sensible move is unglamorous: test your 25(OH)D, correct a genuine deficiency with a modest dose, retest, and treat vitamin D as a foundation to get right before chasing more exotic interventions.